As toxic tort claims alleging chronic illness from alleged chemical exposure continue to rise nationwide, the recent Kansas federal court decision in Jefferies v. Harcros Chemicals Inc., 2026 WL 958172, (April 9, 2026), highlights the power of statutes of repose, which can bar latent disease claims, even when the injury is discovered decades after exposure.
Case Background
In Jefferies, plaintiffs living near the defendant’s chemical manufacturing facility alleged that years of ethylene oxide (EtO) emissions caused cancer and miscarriages, some dating back decades. However, the Kansas statute of repose imposes a strict 10-year cutoff: No claim may proceed for exposures more than 10 years before suit, regardless of when the injury came to light. Seizing on this statute, the defendants filed a motion to dismiss, arguing that the plaintiffs’ claims were time-barred. Agreeing with the defendants, the court rejected arguments that the discovery rule, ongoing emissions, and a continuing duty to warn tolled the statute of repose, emphasizing that the statute is a “general grant of immunity” that abolishes claims arising outside its window.
Latent Disease Exception for Product Liability Claims — Narrow and Inapplicable
Notably, Kansas has a statutory latent disease exception under the Kansas Product Liability Act (KPLA), which plaintiffs argued is applicable because the facility’s emissions stemmed from product manufacturing. The court disagreed, holding that the exception is strictly limited to product liability actions, which require proof that a defect in a product (whether in design, manufacturing, or warnings) directly caused the plaintiff’s injury. By contrast, the Jefferies plaintiffs’ injuries were not tied to any defective product they sold or used but to toxic emissions released during the manufacturing process.
In the court’s view, harm from environmental emissions, unlike harm from a defective product, does not fall within the scope of the KPLA’s latent disease exception. A close look at the legislative history of this statute reinforced that the exception was crafted for cases in which latent disease arises from exposure to the product itself, not from pollution or its manufacturing byproducts. As a result, the plaintiffs could not invoke the exception, and their claims based on exposures more than ten years before suit were barred.
Statutes of Repose Not Uncommon Elsewhere
Kansas is not alone. Many states have statutes of repose that serve as absolute deadlines, cutting off claims after a fixed period from the defendant’s last act, even if the injury is not yet known. Unlike statutes of limitations, statutes of repose are generally not tolled by the discovery of injury, ongoing wrongful conduct, or a continuing duty to warn. Only in rare exceptions, such as claims based on fraud or explicit legislative carve-outs for latent disease, may the period be extended — and these exceptions are often narrowly construed.
For manufacturers whose facilities may be a target for these types of claims, this means:
- Carefully analyze and document the timeline of alleged exposures and injuries.
- Assert statute of repose defenses early, especially in cases involving cancer or other latent diseases.
- Recognize that product liability exceptions for latent disease are often limited to defective product claims, not environmental or facility emission cases.
Bottom Line
The Jefferies case underscores the harsh reality that statutes of repose can confer legal finality on defendants, regardless of when injuries are discovered or when exposure continues. For companies facing historical toxic tort allegations, especially those involving latent cancers or reproductive harms, understanding the interplay between statutes of repose and latent-disease exceptions is key.
The material contained in this communication is informational, general in nature and does not constitute legal advice. The material contained in this communication should not be relied upon or used without consulting a lawyer to consider your specific circumstances. This communication was published on the date specified and may not include any changes in the topics, laws, rules or regulations covered. Receipt of this communication does not establish an attorney-client relationship. In some jurisdictions, this communication may be considered attorney advertising.
